Literature DB >> 31773214

Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes.

Shinji Ogura1, Shoichiro Yonei1, Tomohiko Tanigawa1, Masahiro Akimoto1, Aki Sakurai1, Yuriko Fujita1, Chisako Ito1, Yoshinobu Aisa1, Tomonori Nakazato2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31773214     DOI： 10.1007/s00277-019-03863-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  1 in total

1.  Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome.

Authors:  Cong Shi; Shengping Gong; An Wu; Tingting Niu; Ningning Wu; Yi Zhang; Guifang Ouyang; Qitian Mu
Journal:  Cancer Manag Res       Date:  2022-06-04       Impact factor: 3.602
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.